JUL 11, 2017 03:47 PM PDT

First Vaccine to Show Protection Against Gonorrhea

WRITTEN BY: Xuan Pham

The World Health Organization recently reported on the alarming rise of “super gonorrhea” that can outmaneuver our current arsenal of antibiotics. In response, researchers are working harder than ever on a gonorrhea vaccine, and a recent study demonstrated some promise for such a vaccine in the future.

Image credit: Pixabay.com

The CDC reports that gonorrhea is the “second most commonly reported notifiable disease in the United States,” affecting more than 700,000 Americans every year. The disease is caused by the bacterium Neisseria gonorrhoeae, which spread through unprotected sex with an infected individual. Once in the host, the pathogen can cause to pelvic inflammatory disease, which, for women, can lead to infertility, ectopic pregnancy, and chronic pelvic pain.

"The bacteria that cause gonorrhea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them," explained Dr. Teodora Wi, Medical Officer, Human Reproduction, at WHO. "These cases may just be the tip of the iceberg, since systems to diagnose and report untreatable infections are lacking in lower-income countries where gonorrhea is actually more common.”

In response, researchers from New Zealand recently published their results on a gonorrhea vaccine that, for the first time, showed protection against the infection. In about 15,000 young people, the vaccine cut infections by about a third.

Surprisingly, this vaccine for gonorrhea did not start out as a vaccine specific to the Neisseria gonorrhoeae pathogen. Rather, researchers noticed that a vaccine for meningitis B seemed to offer cross protection against gonorrhea too. Upon closer investigation, the scientists noted the bacteria responsible for the two diseases are close relatives that share the same genus (Neisseria meningitides and Neisseria gonorrhoeae). About a third of the teens that were vaccinated against meningitis B between 2004 and 2006 in New Zealand also had protection against gonorrhea that lasted for about two years.

"This is the first time a vaccine has shown any protection against gonorrhea,” said Dr. Helen Petousis-Harris, one of the researchers. "At the moment, the mechanism behind this immune response is unknown, but our findings could inform future vaccine development." She noted that exposure to the pathogen does not naturally induce immunity or resistance; thus, immunity has to come from an external source.

“To control gonorrhoea, we need new tools and systems for better prevention, treatment, earlier diagnosis, and more complete tracking and reporting of new infections, antibiotic use, resistance and treatment failures,” said Dr. Marc Sprenger, Director of Antimicrobial Resistance at WHO. “Specifically, we need new antibiotics, as well as rapid, accurate, point-of-care diagnostic tests – ideally, ones that can predict which antibiotics will work on that particular infection – and longer term, a vaccine to prevent gonorrhea.”

Additional sources: BBC, WHO

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl...
APR 25, 2018
Clinical & Molecular DX
APR 25, 2018
Why is dementia going unnoticed in hospitals?
A study in the UK showed that while the rate of diagnosis for dementia is improving, more than a third of all dementia patients still go undiagnosed. The n...
MAY 11, 2018
Cardiology
MAY 11, 2018
Gene Therapy to Reduce Risk of Cardiac Arrhythmia
During recovery from a heart attack, the danger is far from over. In a new study from scientists at the University of Bonn and an international team of col...
JUN 08, 2018
Clinical & Molecular DX
JUN 08, 2018
Early Detection of Tooth Decay from Bacterial Invasion
We all get cavities, but have we ever thought much about the biology of the process? From the Akson Russian Science Communication Association, scientists i...
JUN 28, 2018
Cardiology
JUN 28, 2018
"Prehab" Prior to Heart Surgery Boosts Post-Op Recovery
Canadian doctors are promoting the idea of “prehabilitation” for elderly heart disease patients awaiting heart surgery. “Prehab” of...
SEP 15, 2018
Genetics & Genomics
SEP 15, 2018
Data-based Health Management Tool for Aortic Aneurysm
This tool might be extrapolated for many other disorders, and may free patients from repeated doctor visits....
Loading Comments...